Loading clinical trials...
Loading clinical trials...
EFFICACY EVALUATION OF GREAT OCCIPITAL NERVE ELECTRICAL STIMULATION ON REBOUND HEADACHE AFTER WITHDRAWAL IN MEDICATION OVERUSE HEADACHE OCCURING IN MIGRAINE PATIENTS (SENGO-CAM Study)
SENGO-CAM study is a sham-controlled simple blind trial which aim is to study the efficacy of great occipital nerve stimulation (GONS) associated with medication withdrawal in the treatment of medication overuse headache occurring in migraine patients.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Neurology department - La timone
Marseille, France
Neurosurvery department
Nice, France
Headache Emergency Center
Paris, France
Neurology department - CHU Rangueil
Toulouse, France
Start Date
November 1, 2010
Primary Completion Date
January 1, 2011
Completion Date
December 1, 2012
Last Updated
March 18, 2024
30
ACTUAL participants
great occipital nerve stimulation
DEVICE
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07476053